Cannabis Law Report | How to order Skittles Moonrock online
Learn where to buy CBD online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
👉 Click here to Visit our shop! 🛒
The Ukrainian government approved a list that includes conditions that qualify patients to use medical marijuana. The cannabis law of Ukraine was passed by President Volodymyr Zelensky last month.
The Ministry of Health of Ukraine released a list of 20 conditions that qualify patients to receive medical cannabis. Additional conditions may be added if deemed medically appropriate.
These conditions include Parkinson’s, childhood epilepsy, Parkinson’s, neuropathy, shingles and spinal cord injuries. The ministry noted that in the future, a medical advisory panel could approve more conditions.
Read the full report
Official Govt Statement
The Ministry of Health has approved the list of diseases and conditions for which medical cannabis will be prescribed 09/27/2024 3644
The Ministry of Health has established the specifics of prescription and use of medical marijuana medicines produced in pharmacies. The list of conditions and diseases for which the medicines will be prescribed has also been approved. The list is based upon the most recent research and evidence for effectiveness. It will be revised periodically as new research evidence becomes accessible.
Only electronic prescriptions from a primary physician or a specialist physician can be used to obtain medical cannabis-based medicines. The electronic health care system will store data on the appointment.
The patient must have one of the following diagnoses. (In brackets are the codes from the International Statistical Classification of Diseases and Related Health Problems – Tenth Revision).
Chronic or neuropathic (R52.2) pain and/or spasticity due to the following diseases
malignant neoplasms (C00 – C97);
diabetic neuropathy (E10.4, E11.4, E12.4, E13.4, E14.4);
Multiple sclerosis (G35);
Damage to the trigeminal nerve (G50) or facial nerve (G51);
The shingles-induced neuralgia (G53.0);
Damage to nerve roots and plexuses of the G54;
Compression of nerve roots and plexuses (G55)
Mononeuropathy of upper limb (G56);
Mononeuropathy of lower limb (G57);
Polyneuropathies (G60-G64) and other lesions of peripheral nervous system
Other paralytic syndromes and cerebral palsy (G80-G83);
Spinal cord injuries (S14.0 S14.1, T09.3, T91.3), S34.0 S34.1 S34.3 and S34.7, and S34.1 S34.3 T91. 3);
Intracranial injuries (S06)
Treatment of neoplasms can cause nausea and vomiting (R11).
Parkinson’s disease (G20), de la Tourette’s syndrome (F95.2).
Refractory (drug resistant) epilepsy G40 – G41
Diseases causing seizures in childhood: Lennox-Gastaut syndrome (G40.4), Dravet syndrome (G40.4), tuberous sclerosis (Q85.1).
Weight loss associated with anorexia in patients with HIV disease (B20 to B24).
Other diseases (A00-T98) – only if the medical and advisory committee has given an opinion.
It is generally used to describe situations where the use of another drug does not achieve the desired therapeutic effect or has side effects that are not well tolerated by patients. The doctor will determine the dosage and method of taking the cannabis-based medicinal product, taking into consideration the patient’s weight, age, health status, and any concomitant illnesses. Children can be prescribed these drugs as well, but only if their ratio of cannabidiol and tetrahydrocannabinol is greater than 20:1, with a maximum daily dose of 25 mg/kg body weight. At the same time, medicines based on medical cannabis are not prescribed to pregnant and breastfeeding women (in the case of using medicines with tetrahydrocannabinol); Patients with severe personality disorders, including schizophrenia or other psychotic disorders (except depression associated with the underlying illness), or a family or personal history of schizophrenia. Hypersensitivity to cannabinoids, or any other excipient in the medicine, is a contraindication. Patients with moderate or severe liver disease are not recommended to take cannabis medicinal products, or they can be prescribed as long as the dosage is reduced. If the desired therapeutic effects are not achieved within 4-12 weeks, or if there are serious adverse reactions (including those relating to mental state), the cannabis-based medicine should be stopped. As a reminder: all activities related to the medical use of cannabis will be strictly regulated by the state. The recreational (nonmedical) usage of cannabis is still prohibited.
Source: https://moz.gov.ua/uk/moz-zatverdilo-perelik-hvorob-i-staniv-za-yakih-priznachatimetsya-medichnij-kanabis
Leave a Reply
Want to join the discussion?Feel free to contribute!